Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer.
Jenna BhimaniKelli O'ConnellSonia PersaudVictoria S BlinderRachael P Burganowski-DoudIsaac J ErgasGrace B GallagherJennifer J GriggsNarre HeonTatjana KolevskaYuriy KotsurovskyyCandyce H KroenkeCecile A LaurentRaymond LiuKanichi G NakataDonna R RiveraJanise M RohSara M TabatabaiEmily ValiceElisa V BanderaErin J Aiello BowlesLawrence H KushiElizabeth D KantorPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
These associations highlight that vulnerable patient populations may be less likely to receive guideline care and thus real-world studies are essential to understanding how the use of non-guideline regimens impacts patient outcomes in these groups.